Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial [CORRESPONDENCE]
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Poveda, Selle, Hilpert, Reuss, Savarese, Vergote, Witteveen, Bamias, Scotto, Mitchell, Pujade-Lauraine Tags: CORRESPONDENCE Source Type: research